Mens Health Conference
The exclusion of men and boys from the larger debate on health equality has become "normal" with men often absent from national health objectives and no specific focus on male-centered health care. Morbidity and mortality rates in males in the United States and abroad are striking.
We should be creating a culture that promotes good health for all people through healthy development across the lifespan.
Shedding light on how government policies as well as public attention have grown to accept poorer male health outcomes is a task that needs to be dissected and attended in public health, health education, health promotion, and community involvement.
This conference intends to review, discuss, and fullfill the need to better understand gender specific issues relating to benign and malignant prostate disease, hypogonadism and sexual dysfunctions.
Prostate Cancer Conference
Prostate Cancer is the most common solid organ malignancy diagnosed in men. Unlike other solid organ malignancies, the challenge in prostate cancer is to confidently identify men with moderate and high-grade cancers who would most benefit from aggressive therapy. Uniquely among solid organ cancers, imaging has not been a traditional part of the workup of prostate cancer, which has relied instead on transrectal US-guided template biopsy.
Over the past few years, MR imaging has emerged as the best imaging modality to detect, grade and stage prostate cancer. This unique one-day course will provide a comprehensive overview of the utility of multiparametric MR imaging for comprehensive cancer care.
We will discuss all relevant MR imaging parameters for prostate cancer (T2, perfusion, diffusion, and spectroscopy) and discuss new standardized MR reporting algorithms for prostate cancer. In conjunction with the Yale Departments of Urology, Pathology, Diagnostic Radiology, and Radiation Oncology, we will review application of MR Imaging in surgical planning for robotic prostatectomy, prostate biopsy planning, active surveillance and radiation planning. We will also discuss state-of-the-art MR/ US fusion biopsy and direct MR-guided planning for biopsy and treatment. The course will also include an opportunity for participants to interact with industry partners.
The primary goal of this conference is to provide urologists, radiologists, primary care physicians and interventional radiologists with a comprehensive review of advances in prostate imaging, biopsy, and focal minimally invasive ablative therapy of prostate cancer. The course is designed for practicing and academic urologists, radiologists, primary care physicians, and interventional radiologists who are interested in learning about and adopting MRI into the diagnosis and management of prostate cancer – this will specifically include targeted prostate biopsy and focal minimally invasive ablative therapy for managing prostate cancer. Selecting candidates for these novel treatment options will also be emphasized.